期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
人源抗狂犬病毒单克隆抗体载体的构建及烟草转基因研究 被引量:6
1
作者 陈超 张铁钢 《生物学通报》 北大核心 2011年第2期46-49,共4页
为了构建高效表达人源抗狂犬病毒单克隆抗体载体,首先对人源抗狂犬病毒抗体(SO57)重链和轻链编码基因的密码子进行偏好性改造,添加增强外源基因表达的控制元件,然后分别与花椰菜花叶病毒35s启动子和木薯叶脉花叶病毒启动子融合,连接至... 为了构建高效表达人源抗狂犬病毒单克隆抗体载体,首先对人源抗狂犬病毒抗体(SO57)重链和轻链编码基因的密码子进行偏好性改造,添加增强外源基因表达的控制元件,然后分别与花椰菜花叶病毒35s启动子和木薯叶脉花叶病毒启动子融合,连接至植物表达载体pBI121上,然后将构建好的载体转入农杆菌LB4404,采用叶盘法转化烟草叶片。用分子生物学技术,对6株转基因烟草进行检测,电泳检测结果均为阳性。用酶联接免疫吸附剂法,检测6株烟草叶片中人源抗狂犬病毒单克隆抗体的表达。结果表明,6株烟草均成功表达人源抗狂犬病毒抗体。 展开更多
关键词 人源抗狂犬病毒单克隆抗体载体 烟草转基因病毒
下载PDF
Genetic Engineering of Tobacco with Double Resistance to Both Virus and Insect
2
作者 梁晓友 米景九 +1 位作者 潘乃隧 陈章良 《Developmental and Reproductive Biology》 1994年第1期29-36,T001,共9页
Expression vector pE14 with double resistance to virus and insect was constructed by inserting CW-cp gene and Bt-toxin gene one by into T-DNA of the same binary vector pE3. Tobacco was then transformed with Agrbacter... Expression vector pE14 with double resistance to virus and insect was constructed by inserting CW-cp gene and Bt-toxin gene one by into T-DNA of the same binary vector pE3. Tobacco was then transformed with Agrbacterium tumefaciens (At)GV311-SE carrying PE14. Nopaline assay and PCR amplification confirmed that both CW-cp gene and Bt-toxin gene had been introduced into tobacco genome by T-DNA of PE3. Test attack with virus and demonstrated, in some of the transgenic plants, double resistance to both infection by CMV and damage by Manduca sexta. 展开更多
关键词 Coiistruction of vector Transformation of tobacco Double resistance to virus and insect
下载PDF
Immunogenicity and virus-like particle formation of rotavirus capsid proteins produced in transgenic plants 被引量:4
3
作者 YANG YanMei LI Xia +4 位作者 YANG Hui QIAN Yuan ZHANG You FANG RongXiang CHEN XiaoYing 《Science China(Life Sciences)》 SCIE CAS 2011年第1期82-89,共8页
The human pathogen, group A rotavirus, is the most prevalent cause of acute infantile and pediatric gastroenteritis worldwide, especially in developing countries. There is an urgent demand for safer, more effective an... The human pathogen, group A rotavirus, is the most prevalent cause of acute infantile and pediatric gastroenteritis worldwide, especially in developing countries. There is an urgent demand for safer, more effective and cheaper vaccines against rotavirus infection. Plant-derived antigens may provide an exclusive way to produce economical subunit vaccines. Virus-like particles, constituting viral capsid proteins without viral nucleic acids, are considered a far safer candidate compared with live attenuated viral vaccines. In this study, the rotavirus capsid proteins VP2, VP6 and VP7 were co-expressed in transgenic tobacco plants, and their expression levels, formation of rotavirus-like particles (RV VLPs) and immunogenicity were extensively studied. Quantitative real-time RT-PCR and Western blot analysis revealed that the expression level of vp6 was the highest while vp7 was expressed at the lowest levels. The RV VLPs were purified from transgenic tobacco plants and analyzed by electron microscopy and Western blot. Results indicated that the plant-derived VP2, VP6 and VP7 proteins self-assembled into 2/6 or 2/6/7 RV VLPs with a diameter of 60-80 nm. When orally delivered into mice with cholera toxin as an adjuvant, the total soluble protein extracted from transgenic tobacco plants induced rotavirus-specific antibodies comparable with those of attenuated rotavirus vaccines, while VP 2/6/7 induced higher serum IgG and fecal IgA titers compared with VP 2/6. 展开更多
关键词 ROTAVIRUS virus-like particles transgenic plant oral vaccine IMMUNOGENICITY
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部